RxDoctor Payments Data

Robert Greenfield

Cardiovascular Disease · Fountain Valley, CANPI 1649307000

Payments from drug & device makers

$26,978in general payments, 2019–2025

Across 147 payments — averaging $183.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$15K
  • Sanofi-aventis U.S. LLC$4K
  • Regeneron Healthcare Solutions, Inc.$4K
  • Medtronic$930
  • Novartis$500
  • Boehringer Ingelheim$190
  • plus $2K from 24 others

What the payments were for

  • Consulting fees$2,5009%
  • Speaking & faculty fees$19,17471%
  • Travel & lodging$5052%
  • Food & beverage$4,77618%
  • Education$230%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,978 in reported general payments places this provider in the 80th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California

Other cardiovascular disease in Fountain Valley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →